129 related articles for article (PubMed ID: 23065853)
1. Influence of age on prognosis of young patients with uveal melanoma: a matched retrospective cohort study.
Kaliki S; Shields CL; Mashayekhi A; Ganesh A; Furuta M; Shields JA
Eur J Ophthalmol; 2013; 23(2):208-16. PubMed ID: 23065853
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.
Shields CL; Kaliki S; Furuta M; Mashayekhi A; Shields JA
Retina; 2012 Jul; 32(7):1363-72. PubMed ID: 22466491
[TBL] [Abstract][Full Text] [Related]
3. Iris melanoma: features and prognosis in 317 children and adults.
Shields CL; Kaliki S; Shah SU; Luo W; Furuta M; Shields JA
J AAPOS; 2012 Feb; 16(1):10-6. PubMed ID: 22370659
[TBL] [Abstract][Full Text] [Related]
4. UVEAL METASTASIS BASED ON PATIENT AGE IN 1,111 PATIENTS: Comparison of Clinical Features and Outcomes Per Age Category.
Shields CL; Acaba-Berrocal LA; Selzer EB; Mayro EL; Newman JH; Malik K; Welch RJ; Shields JA
Retina; 2020 Feb; 40(2):204-213. PubMed ID: 31972789
[TBL] [Abstract][Full Text] [Related]
5. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.
Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
Ophthalmology; 2013 Oct; 120(10):2066-71. PubMed ID: 23664467
[TBL] [Abstract][Full Text] [Related]
6. Metastasis from uveal melanoma associated with congenital ocular melanocytosis: a matched study.
Mashayekhi A; Kaliki S; Walker B; Park C; Sinha N; Kremer FZ; Shields CL; Shields JA
Ophthalmology; 2013 Jul; 120(7):1465-8. PubMed ID: 23522968
[TBL] [Abstract][Full Text] [Related]
7. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
Ophthalmic Oncology Task Force
Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
[TBL] [Abstract][Full Text] [Related]
8. The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group.
Al-Jamal RT; Cassoux N; Desjardins L; Damato B; Konstantinidis L; Coupland SE; Heimann H; Petrovic A; Zografos L; Schalenbourg A; Velazquez-Martin JP; Krema H; Bogdali A; Markiewicz A; Romanowska-Dixon B; Metz CH; Biewald E; Bornfeld N; Kiratli H; Bronkhorst IH; Jager MJ; Marinkovic M; Fili M; Seregard S; Frenkel S; Pe'er J; Salvi SM; Rennie IG; Rospond-Kubiak I; Kociecki J; Kiilgaard JF; Heegaard S; Cohen VM; Sagoo MS; Amiryan A; Saakyan S; Eide N; Krohn J; Midena E; Parrozzani R; Grange JD; Kilic E; Blasi MA; Saornil MA; Kivelä TT
Ophthalmology; 2016 Apr; 123(4):898-907. PubMed ID: 26854035
[TBL] [Abstract][Full Text] [Related]
9. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
[TBL] [Abstract][Full Text] [Related]
10. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
Park SJ; Oh CM; Yeon B; Cho H; Park KH
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
[TBL] [Abstract][Full Text] [Related]
11. Posterior uveal melanoma in young patients treated with proton beam therapy.
Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
[TBL] [Abstract][Full Text] [Related]
12. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.
Ewens KG; Kanetsky PA; Richards-Yutz J; Al-Dahmash S; De Luca MC; Bianciotto CG; Shields CL; Ganguly A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5721-9. PubMed ID: 23821189
[TBL] [Abstract][Full Text] [Related]
13. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
14. Survival from uveal melanoma in Western Australia 1981-2005.
Chew AL; Spilsbury K; Isaacs TW
Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
[TBL] [Abstract][Full Text] [Related]
15. Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide.
Shields CL; Kaliki S; Hutchinson A; Nickerson S; Patel J; Kancherla S; Peshtani A; Nakhoda S; Kocher K; Kolbus E; Jacobs E; Garoon R; Walker B; Rogers B; Shields JA
Ophthalmology; 2013 Apr; 120(4):766-72. PubMed ID: 23290981
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of liver metastases from uveal melanoma.
Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
[TBL] [Abstract][Full Text] [Related]
17. LARGE UVEAL MELANOMA (≥10 MM THICKNESS): Clinical Features and Millimeter-by-Millimeter Risk of Metastasis in 1311 Cases. The 2018 Albert E. Finley Lecture.
Shields CL; Sioufi K; Robbins JS; Barna LE; Harley MR; Lally SE; Say EAT; Mashayekhi A; Shields JA
Retina; 2018 Oct; 38(10):2010-2022. PubMed ID: 29528980
[TBL] [Abstract][Full Text] [Related]
18. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.
Shields CL; Furuta M; Thangappan A; Nagori S; Mashayekhi A; Lally DR; Kelly CC; Rudich DS; Nagori AV; Wakade OA; Mehta S; Forte L; Long A; Dellacava EF; Kaplan B; Shields JA
Arch Ophthalmol; 2009 Aug; 127(8):989-98. PubMed ID: 19667335
[TBL] [Abstract][Full Text] [Related]
19. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
Kim IK; Lane AM; Gragoudas ES
Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
[TBL] [Abstract][Full Text] [Related]
20. ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis.
Caltabiano R; Puzzo L; Barresi V; Ieni A; Loreto C; Musumeci G; Castrogiovanni P; Ragusa M; Foti P; Russo A; Longo A; Reibaldi M
Pathol Res Pract; 2016 Nov; 212(11):980-987. PubMed ID: 27546281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
